8-K Q4 2019 EARNINGS

Company

CytomX Therapeutics, Inc.

Filed

February 27, 2020

Period of Report

February 27, 2020

Accession Number

0001564590-20-007430

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →